Results 21 to 30 of about 536 (108)

Antipsychotics and Risks of Cardiovascular and Cerebrovascular Diseases and Mortality in Dwelling Community Older Adults

Pharmaceuticals
This study aims to investigate the effect of antipsychotic agents on cardiovascular and cerebrovascular diseases (CVD/CEV) and mortality risks in the older population living in a community.
Sylvie Perreault, Laurie-Anne Boivin Proulx, Judith Brouillette, Stéphanie Jarry, Marc Dorais   +4 more
doaj   +1 more source

Şizofrenide ilaç sağaltımı

Psychiatry and Clinical Psychopharmacology, 2021
Pharmacotheraphy in schizophrenia begins with the discovery of chlorpromazine. Later the synthesis of other various antipsychotics has led psychotic patients to get out of hospitals and live in the society.
Leyla Gülseren, Almıla Erol
doaj  

Pharmacotherapy of schizophrenia [PDF]

Iranian Journal of Psychiatry, 2006
Traditionally, schizophrenia was considered to be a severe psychiatric disorder, with a chronic course and an unfavorable outcome. Throughout history, there has been incidence of schizophrenia, roughly one percent of the population, consistently, in ...
Shahin Akhondzadeh, Khosro Afkham
doaj   +2 more sources

Psychopharmacological Treatment in Patients with Heart Failure: A Narrative Review of Mood Stabilizers and Antipsychotics

Brain Sciences
Heart failure (HF) is a leading cause of morbidity and mortality worldwide, and its co-occurrence with psychiatric disorders poses significant therapeutic challenges. This narrative review examines the safe use of psychopharmacological agents in patients
Błażej Pilarski, Szymon Florek, Alexander Suchodolski, Mariola Szulik, Robert Pudlo   +4 more
doaj   +1 more source

Sertindole in the Management of Schizophrenia

Journal of Central Nervous System Disease, 2011
Nowadays, new schizophrenia treatments are more ambitious than ever, aiming not only to improve psychotic symptoms, but also quality of life and social reinsertion.
Mario F. Juruena, Eduardo Ponde00C9; De Sena, Irismar Reis De Oliveira   +2 more
doaj   +1 more source

Association Between Antipsychotic Treatment and Neurological Adverse Events in Pediatric Patients: A Population-Based Cohort Study in Korea

Frontiers in Psychiatry, 2021
Background: Potential adverse effects might be caused by increasing the number of antipsychotic prescriptions. However, the empirical evidence regarding pediatric psychiatric patients is insufficient.
Soo Min Jeon, Susan Park, Soonhak Kwon, Jin-Won Kwon   +3 more
doaj   +1 more source

Twenty-Year Trends in Antipsychotic Utilization in Serbia: A Nationwide Drug Utilization Study

Pharmaceuticals
Background/Objectives: Antipsychotic drug utilization has changed substantially over recent decades, reflecting evolving prescribing practices, drug availability, and treatment guidelines.
Zorana Pavlovic, Milena Stevanovic, Marija Milic, Jelena Filimonovic, Bojana Matejić, Mladen Bogdanovic, Ivana Vukajlovic, Aleksandar Krstić, Miodrag Milenović, Bojana Dunjić Kostić   +9 more
doaj   +1 more source

HOW ASSESS DRUGS IN THE TREATMENT OF ACUTE BIPOLAR MANIA ?

Frontiers in Pharmacology, 2013
Bipolar affective disorder is a serious mental disease associated with significant morbidity and mortality. Good-quality research available to guide treatment strategies remains insufficient, particularly with regard to manic or hypomanic episodes.
Michel eBourin, Florence eThibaut
doaj   +1 more source

Identifying dopamine supersensitivity through a randomized controlled study of switching to aripiprazole from other antipsychotic agents in patients with schizophrenia

Therapeutic Advances in Psychopharmacology, 2022
Background: Aripiprazole has been reported to worsen psychotic symptoms when switching from other antipsychotics, possibly due to dopamine supersensitivity psychosis.
Chia-Hao Ma, Hung-Yu Chan, Ming H. Hsieh, Chen-Chung Liu, Chih-Min Liu, Hai-Gwo Hwu, Ching-Hua Kuo, Wei J. Chen, Tzung-Jeng Hwang   +8 more
doaj   +1 more source

Serotonin Syndrome Triggered by Increasing the Dose of Quetiapine

Clinical Practice and Cases in Emergency Medicine, 2021
Case presentation: An 85-year-old woman with a history of depression treated with polypharmacy including selective serotonin reuptake inhibitor presented to the emergency department with head, and upper and lower limb tremors four hours after increasing ...
Yayoi Miyamatsu, Ryutaro Tanizaki
doaj   +1 more source